Key facts
| Price (PPV) | 70.10 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | célécoxib |
| Class | Antiinflammatory and antirheumatic products |
| ATC code | M01AH01 |
| Manufacturer | PHI |
| Presentation | Boite de 10 |
| Hospital price | 43.80 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement symptomatique des inflammations et des douleurs provoquées par l'ostéoarthrose, la polyarthrite chronique (arthrite rhumatoïde) et par la spondylarthrite ankylosante (maladie de Bechterew). Traitement symptomatique de l'arthrite juvénile idiopathique chez l'enfant et l'adolescent d'un poids corporel supérieur à 25 kg. La décision de prescrire un inhibiteur sélectif de la COX-2 doit tenir compte de l'ensemble des facteurs de risque d'un patient (voir sous «Contre-indications» et «Mises en garde et précautions»).
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
7 other products contain the same active substance as Celephi 200 mg (Célécoxib), at the same strength and in the same dosage form. The prices below are per pack: compare pack sizes before comparing prices.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Isox 200 mg | PROMOPHARM (HIKMA) | Boite de 10 | 76.60 MAD | 7.66 / unit | — |
| Voxcib 200 mg | NOVOPHARMA | Boîte de 10 | 76.60 MAD | 7.66 / unit | — |
| Celebrex 200 mg | VIATRIS PHARMACEUTICALS | Boîte de 10 | 83.20 MAD | 8.32 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Celephi 200 mg | PHI | Boite de 20 | 130.80 MAD | 6.54 / unit |
| Isox 200 mg | PROMOPHARM (HIKMA) | Boite de 20 | 134.90 MAD | 6.75 / unit |
| Voxcib 200 mg | NOVOPHARMA | Boite de 20 | 134.90 MAD | 6.75 / unit |
| Celebrex 200 mg | VIATRIS PHARMACEUTICALS | Boîte de 20 | 150 MAD | 7.50 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Celephi 200 mg
Celephi 200 mg belongs to the antiinflammatory and antirheumatic products therapeutic class. In Morocco, this drug is marketed by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Celephi 200 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Celephi 200 mg
Answers to common questions from Moroccan patients about this drug.